Join Josh Brown, a savvy market strategist, Joe Chernova, an analytical powerhouse, and Brian Belsky, a tech stock expert, as they dive into the tech sector's resurgence. They discuss the NASDAQ 100's recent performance and highlight opportunities in lesser-known tech stocks. The team critically analyzes healthcare investments, contrasting Gilead's uplifting outlook with Merck's struggles. Additionally, they examine the shift towards private market investments and share strategic insights for navigating market volatility while emphasizing long-term investment strategies.